🇺🇸 FDA
Pipeline program

A randomised, assessor-blinded, controlled, healthy volunteer, Phase I study to assess skin irritation and sensitization potential of a novel 5% lidocaine medicated plaster

24EU-Lip03

Phase 1 other active

Quick answer

A randomised, assessor-blinded, controlled, healthy volunteer, Phase I study to assess skin irritation and sensitization potential of a novel 5% lidocaine medicated plaster for None. Healthy subjects is a Phase 1 program (other) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
None. Healthy subjects
Phase
Phase 1
Modality
other
Status
active

Clinical trials